Studies have shown that the effectiveness of metformin in reducing glucose levels in mice is highly dependent on the time at which it is administered, and it remains to be seen whether this applies to humans. There is growing interest in the potential of metformin to trigger the fasting state, and experimentation with its administration time may yield promising results.